Covered recipient · General Payments record
SHERILYN J BENNETT
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$946.74
- Reported across 68 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $536.91 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $304.86 | 22 |
| Acerta Pharma LLC | $74.61 | 5 |
| Exact Sciences Corporation | $37.16 | 2 |
| Phathom Pharmaceuticals, Inc. | $24.32 | 1 |
| Novo Nordisk AS | $21.55 | 1 |
| SHIELD THERAPEUTICS INC | $16.05 | 1 |
| Amgen Inc. | $16.02 | 1 |
| Lilly USA, LLC | $14.61 | 1 |
| GlaxoSmithKline, LLC. | $14.14 | 1 |
| PFIZER INC. | $13.59 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.76 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106514448 | CMS |
| ABBVIE INC. | $5.59 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106514450 | CMS |
| ABBVIE INC. | $30.88 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106514452 | CMS |
| ABBVIE INC. | $21.59 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106514454 | CMS |
| ABBVIE INC. | $13.49 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106514456 | CMS |
| ABBVIE INC. | $21.93 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106514458 | CMS |
| ABBVIE INC. | $22.38 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106514460 | CMS |
| ABBVIE INC. | $8.52 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106514462 | CMS |
| ABBVIE INC. | $12.19 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106514464 | CMS |
| ABBVIE INC. | $6.39 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106514466 | CMS |
| ABBVIE INC. | $5.04 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106514468 | CMS |
| ABBVIE INC. | $8.85 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106514470 | CMS |
| ABBVIE INC. | $13.87 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106514472 | CMS |
| ABBVIE INC. | $7.84 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106514474 | CMS |
| ABBVIE INC. | $20.89 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106514476 | CMS |
| ABBVIE INC. | $17.80 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106514478 | CMS |
| ABBVIE INC. | $13.73 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106514480 | CMS |
| ABBVIE INC. | $9.07 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106514482 | CMS |
| ABBVIE INC. | $13.99 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106514484 | CMS |
| ABBVIE INC. | $5.09 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106514486 | CMS |
| ABBVIE INC. | $15.98 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106514488 | CMS |
| ABBVIE INC. | $11.99 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106514490 | CMS |
| Amgen Inc. | $16.02 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117505497 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.31 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104550178 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.53 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104421015 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.22 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105680455 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.43 | 05/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104721029 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.12 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105375725 | CMS |
| Exact Sciences Corporation | $16.90 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114467767 | CMS |
| Exact Sciences Corporation | $20.26 | 07/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114467774 | CMS |
| GlaxoSmithKline, LLC. | $14.14 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116412765 | CMS |
| Lilly USA, LLC | $14.61 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135949486 | CMS |
| Novo Nordisk Inc | $21.55 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100450431 | CMS |
| PFIZER INC. | $13.59 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132104055 | CMS |
| Phathom Pharmaceuticals, Inc. | $24.32 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151148628 | CMS |
| SHIELD THERAPEUTICS INC | $16.05 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150116055 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.